CEACAM5 and familial pancreatic carcinoma: Synergistic inhibition of stemness-related regulatory metabolisms, including prostanoid and long-chain unsaturated fatty acid metabolic processes, may improve the efficacy of ICB treatment which is aimed at eliminating immune evasion in stemness-high pancreatic cancers with high CEACAM5 expression.